Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

This study has been completed.

Study NCT00397293 Information provided by Ascenta Therapeutics

First Received: November 7, 2006 Last Updated: August 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: August 12, 2010